470 related articles for article (PubMed ID: 25282404)
1. Autophagy in Huntington disease and huntingtin in autophagy.
Martin DD; Ladha S; Ehrnhoefer DE; Hayden MR
Trends Neurosci; 2015 Jan; 38(1):26-35. PubMed ID: 25282404
[TBL] [Abstract][Full Text] [Related]
2. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.
Wong YC; Holzbaur EL
J Neurosci; 2014 Jan; 34(4):1293-305. PubMed ID: 24453320
[TBL] [Abstract][Full Text] [Related]
3. Huntingtin processing in pathogenesis of Huntington disease.
Qin ZH; Gu ZL
Acta Pharmacol Sin; 2004 Oct; 25(10):1243-9. PubMed ID: 15456523
[TBL] [Abstract][Full Text] [Related]
4. Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment?
Lin F; Qin ZH
J Huntingtons Dis; 2013; 2(2):149-57. PubMed ID: 25063512
[TBL] [Abstract][Full Text] [Related]
5. ATTEC: a potential new approach to target proteinopathies.
Li Z; Zhu C; Ding Y; Fei Y; Lu B
Autophagy; 2020 Jan; 16(1):185-187. PubMed ID: 31690177
[TBL] [Abstract][Full Text] [Related]
6. Autophagy regulates the processing of amino terminal huntingtin fragments.
Qin ZH; Wang Y; Kegel KB; Kazantsev A; Apostol BL; Thompson LM; Yoder J; Aronin N; DiFiglia M
Hum Mol Genet; 2003 Dec; 12(24):3231-44. PubMed ID: 14570716
[TBL] [Abstract][Full Text] [Related]
7. Role of chaperone-mediated autophagy in degrading Huntington's disease-associated huntingtin protein.
Qi L; Zhang XD
Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):83-91. PubMed ID: 24323530
[TBL] [Abstract][Full Text] [Related]
8. The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy.
Cortes CJ; La Spada AR
Drug Discov Today; 2014 Jul; 19(7):963-71. PubMed ID: 24632005
[TBL] [Abstract][Full Text] [Related]
9. Primary cilia and autophagic dysfunction in Huntington's disease.
Kaliszewski M; Knott AB; Bossy-Wetzel E
Cell Death Differ; 2015 Sep; 22(9):1413-24. PubMed ID: 26160070
[TBL] [Abstract][Full Text] [Related]
10. Dopamine exacerbates mutant Huntingtin toxicity via oxidative-mediated inhibition of autophagy in SH-SY5Y neuroblastoma cells: Beneficial effects of anti-oxidant therapeutics.
Vidoni C; Castiglioni A; Seca C; Secomandi E; Melone MA; Isidoro C
Neurochem Int; 2016 Dec; 101():132-143. PubMed ID: 27840125
[TBL] [Abstract][Full Text] [Related]
11. Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity.
Krench M; Littleton JT
Fly (Austin); 2013; 7(4):229-36. PubMed ID: 24022020
[TBL] [Abstract][Full Text] [Related]
12. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
[TBL] [Abstract][Full Text] [Related]
13. Clearance of mutant proteins as a therapeutic target in neurodegenerative diseases.
Krainc D
Arch Neurol; 2010 Apr; 67(4):388-92. PubMed ID: 20385902
[TBL] [Abstract][Full Text] [Related]
14. Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin.
Martin DD; Heit RJ; Yap MC; Davidson MW; Hayden MR; Berthiaume LG
Hum Mol Genet; 2014 Jun; 23(12):3166-79. PubMed ID: 24459296
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.
Arndt JR; Chaibva M; Legleiter J
Biomol Concepts; 2015 Mar; 6(1):33-46. PubMed ID: 25741791
[TBL] [Abstract][Full Text] [Related]
16. Targeting mutant huntingtin for the development of disease-modifying therapy.
Appl T; Kaltenbach L; Lo DC; Terstappen GC
Drug Discov Today; 2012 Nov; 17(21-22):1217-23. PubMed ID: 22772050
[TBL] [Abstract][Full Text] [Related]
17. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.
Scappini E; Koh TW; Martin NP; O'Bryan JP
Hum Mol Genet; 2007 Aug; 16(15):1862-71. PubMed ID: 17550941
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
19. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
20. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR
BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
